Meyka Pro banner
iRhythm Technologies, Inc.

iRhythm Technologies, Inc. (IRTC) Stock Overview

Explore iRhythm Technologies, Inc.’s financial performance, market position, analyst ratings, and future outlook.

IRTCNASDAQ
HealthcareMedical - Devices
$123.16
$2.19(1.75%)
U.S. Market opens in 2h 7m

iRhythm Technologies, Inc. (IRTC)

Meyka AI Score

Z

Key Financials

Market Cap4B
P/E Ratio-291.59
EPS (TTM)$-0.64
ROE-0.09%
Fundamental Analysis

AI Price Forecasts

1 Month$147.25
3 Months$187.92
1 Year Target$137.39

IRTC Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of iRhythm Technologies, Inc. (NASDAQ: IRTC) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, iRhythm Technologies, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of IRTC on the NASDAQ shows an RSI of 54.30, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $137.39 for the NASDAQ listing.

Key metrics behind iRhythm Technologies, Inc.'s NASDAQ-traded stock include a P/E ratio of -291.59 and a market capitalization of 4B. Combined with our AI analysis, these give both institutional and retail investors a clear view of IRTC on the NASDAQ.

Price Performance (NASDAQ: IRTC)

1-Day Change
-1.75%
5-Day Change
-6.39%
1-Month Change
3.77%
3-Month Change
7.41%
6-Month Change
-14.60%
Year-to-Date (YTD) Change
-30.59%
1-Year Change
-26.19%
3-Year Change
5.92%
5-Year Change
170.15%
All-Time (Max) Change
372.78%

Contact Information

415 632 5700
699 8th Street, San Francisco, CA, 94103

Company Facts

24,000 Employees
IPO DateOct 20, 2016
CountryUS
Actively Trading

Frequently Asked Questions